Abstract
The “vascular depression” hypothesis postulates that cerebral ischaemic damage to frontal-subcortical circuits predisposes to and/or perpetuates depression in older people, but this concept has been criticized because community studies have failed to demonstrate a robust relationship between depression and vascular disease and because of the apparent inability to define the clinical entity of “vascular depression.” However, evidence clearly demonstrates that depression has a bidirectional relationship with vascular disease (Thomas et al., J Affect Disord 79(1–3):81–95, 2004) and that there is an increase in late-life depression in MRI WMH, which are ischaemic lesions. The explanation for the differences in these findings probably reflects the insensitivity of (peripherally measured) conventional VRFs for actual ischaemic disease in the brain and the differences in samples, with the MRI and pathology studies assessing major depression in secondary care patients while the community studies sample milder cases of depression and one’s which may have a different aetiology. More recent evidence supports a definition of “vascular depression” focusing on a subgroup defined by the burden of WMH and indicates such a subgroup is both robust and clinically important in that it appears to predict poor response to treatment, persistence of depressive symptoms and of neurocognitive impairments, and worse longer-term outcomes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Almeida OP. Vascular depression: myth or reality? Int Psychogeriatr. 2008;20(4):645–52.
Kim JM, Stewart R, Shin IS, Yoon JS. Vascular disease/risk and late-life depression in a Korean community population. Br J Psychiatry. 2004;185:102–7.
Lyness JM, Caine ED, Cox C, King DA, Conwell Y, Olivares T. Cerebrovascular risk factors and later-life major depression. Testing a small-vessel brain disease model. Am J Geriatr Psychiatry. 1998;6(1):5–13.
Lyness JM, Caine ED, King DA, Conwell Y, Cox C, Duberstein PR. Cerebrovascular risk factors and depression in older primary care patients: testing a vascular brain disease model of depression. Am J Geriatr Psychiatry. 1999;7(3):252–8.
Naarding P, Tiemeier H, Breteler MMB, Schoevers RA, Jonker C, Koudstaal PJ, et al. Clinically defined vascular depression in the general population. Psychol Med. 2007;37(3):383–92.
Kim J-M, Stewart R, Kim S-W, Yang S-J, Shin I-S, Yoon J-S. Vascular risk factors and incident late-life depression in a Korean population. Br J Psychiatry. 2006;189:26–30.
Lyness JM, King DA, Conwell Y, Cox C, Caine ED. Cerebrovascular risk factors and 1-year depression outcome in older primary care patients. Am J Psychiatry. 2000;157(9):1499–501.
Richardson J, Kerr SRJ, Shaw F, Kenny RA, O’Brien JT, Thomas AJ. A study of orthostatic hypotension in late-life depression. Am J Geriatr Psychiatry. 2009;17(11):996–9. doi:10.1097/JGP.0b013e3181b4bf35.
Vasudev A, O’Brien JT, Tan MP, Parry SW, Thomas AJ. A study of orthostatic hypotension, heart rate variability and baroreflex sensitivity in late-life depression. J Affect Disord. 2011;131:374–8 (Epub 2010/12/03).
Thomas AJ, Kalaria RN, O’Brien JT. Depression and vascular disease: what is the relationship? J Affect Disord. 2004;79(1–3):81–95.
Ford DE, Mead LA, Chang PP, Cooper-Patrick L, Wang NY, Klag MJ. Depression is a risk factor for coronary artery disease in men: the precursors study. Arch Intern Med. 1998;158(13):1422–6.
Pratt LA, Ford DE, Crum RM, Armenian HK, Gallo JJ, Eaton WW. Depression, psychotropic medication, and risk of myocardial infarction. Prospective data from the Baltimore ECA follow-up. Circulation. 1996;94(12):3123–9.
Jonas BS, Mussolino ME. Symptoms of depression as a prospective risk factor for stroke. Psychosom Med. 2000;62(4):463–71.
Salaycik KJ, Kelly-Hayes M, Beiser A, Nguyen A-H, Brady SM, Kase CS, et al. Depressive symptoms and risk of stroke: the Framingham Study. Stroke. 2007;38(1):16–21.
Herrmann LL, Le Masurier M, Ebmeier KP. White matter hyperintensities in late life depression: a systematic review. J Neurol Neurosurg Psychiatry. 2008;79(6):619–24.
Sheline YI, Price JL, Vaishnavi SN, Mintun MA, Barch DM, Epstein AA, et al. Regional white matter hyperintensity burden in automated segmentation distinguishes late-life depressed subjects from comparison subjects matched for vascular risk factors. Am J Psychiatry. 2008;165(4):524–32.
Thomas AJ, O’Brien JT, Davis S, Ballard C, Barber R, Kalaria RN, et al. Ischemic basis for deep white matter hyperintensities in major depression: a neuropathological study. Arch Gen Psychiatry. 2002;59(9):785–92.
Thomas AJ, Perry R, Kalaria RN, Oakley A, McMeekin W, O’Brien JT. Neuropathological evidence for ischemia in the white matter of the dorsolateral prefrontal cortex in late-life depression. Int J Geriatr Psychiatry. 2003;18(1):7–13.
Thomas AJ, O’Brien JT, Barber R, McMeekin W, Perry R. A neuropathological study of periventricular white matter hyperintensities in major depression. J Affect Disord. 2003;76:49–54.
Wolf PA, D’Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham Study. Stroke. 1991;22(3):312–8.
Colloby SJ, Vasudev A, et al. Relationship of orthostatic blood pressure to white matter hyperintensities and subcortical volumes in late-life depression. Br J Psychiatry. 2011;199:404–10.
Krishnan MS, O’Brien JT, Firbank MJ, Pantoni L, Carlucci G, Erkinjuntti T, et al. Relationship between periventricular and deep white matter lesions and depressive symptoms in older people: the LADIS Study. Int J Geriatr Psychiatry. 2006;21:983–9.
Teodorczuk A, Firbank MJ, Pantoni L, Poggesi A, Erkinjuntti T, Wallin A, et al. Relationship between baseline white-matter changes and development of late-life depressive symptoms: 3-year results from the LADIS study. Psychol Med. 2010;40(4):603–10.
Teodorczuk A, O’Brien JT, Firbank MJ, Pantoni L, Poggesi A, Erkinjuntti T, et al. White matter changes and late-life depressive symptoms: longitudinal study. Br J Psychiatry. 2007;191:212–7.
Steffens DC, Krishnan KRR, Crump C, Burke GL. Cerebrovascular disease and evolution of depressive symptoms in the cardiovascular health study. Stroke. 2002;33(6):1636–44.
Godin O, Dufouil C, Maillard P, Delcroix N, Mazoyer B, Crivello F, et al. White matter lesions as a predictor of depression in the elderly: the 3C-Dijon study. Biol Psychiatry. 2008;63(7):663–9.
Kohler S, Thomas AJ, Barnett NA, O’Brien JT. The pattern and course of cognitive impairment in late-life depression. Psychol Med. 2010;40(4):591–602.
Kramer-Ginsberg E, Greenwald BS, Krishnan KR, Christiansen B, Hu J, Ashtari M, et al. Neuropsychological functioning and MRI signal hyperintensities in geriatric depression. Am J Psychiatry. 1999;156(3):438–44.
Kohler S, Thomas AJ, Lloyd A, Barber R, Almeida OP, O’Brien JT. White matter hyperintensities, cortisol levels, brain atrophy and continuing cognitive deficits in late-life depression. Br J Psychiatry. 2010;196(2):143–9.
Simpson S, Baldwin RC, Jackson A, Burns AS. Is subcortical disease associated with a poor response to antidepressants? Neurological, neuropsychological and neuroradiological findings in late life depression. Psychol Med. 1998;28:1015–26.
Taylor WD, Steffens DC, MacFall JR, McQuoid DR, Payne ME, Provenzale JM, et al. White matter hyperintensity progression and late-life depression outcomes. Arch Gen Psychiatry. 2003;60(11):1090–6.
O’Brien J, Ames D, Chiu E, Schweitzer I, Desmond P, Tress B. Severe deep white matter lesions and outcome in elderly patients with major depressive disorder: follow up study. BMJ. 1998;317(7164):982–4.
Hickie I, Scott E, Mitchell P, Wilhelm K, Austin M-P, Bennett B. Subcortical hyperintensities on magnetic resonance imaging: clinical correlates and prognostic significance in patients with severe depression. Biol Psychiatry. 1995;37:151–60.
Taylor WD, MacFall JR, Payne ME, McQuoid DR, Provenzale JM, Steffens DC, et al. Late-life depression and microstructural abnormalities in dorsolateral prefrontal cortex white matter. Am J Psychiatry. 2004;161(7):1293–6.
Thomas AJ, Ferrier IN, Kalaria RN, Davis S, O’Brien JT. Cell adhesion molecule expression in the dorsolateral prefrontal cortex and anterior cingulate cortex in major depression in the elderly. Br J Psychiatry. 2002;181:129–34.
Alexopoulos GS, Kiosses DN, Choi SJ, Murphy CF, Lim KO. Frontal white matter microstructure and treatment response of late-life depression: a preliminary study. Am J Psychiatry. 2002;159(11):1929–32.
Alexopoulos GS, Murphy CF, Gunning-Dixon FM, Latoussakis V, Kanellopoulos D, Klimstra S, et al. Microstructural white matter abnormalities and remission of geriatric depression. Am J Psychiatry. 2008;165(2):238–44.
Alexopoulos GS, Meyers BS, et al. Vascular depression hypothesis. Arch Gen Psychiatry. 1997;54(10):915–92.
Sneed JR, Rindskopf D, Steffens DC, Krishnan KRR, Roose SP. The vascular depression subtype: evidence of internal validity. Biol Psychiatry. 2008;64(6):491–7.
Taragano FE, Allegri R, Vicario A, Bagnatti P, Lyketsos CG. A double blind, randomized clinical trial assessing the efficacy and safety of augmenting standard antidepressant therapy with nimodipine in the treatment of “vascular depression”. Int J Geriatr Psychiatry. 2001;16(3):254–60.
Taragano FE, Bagnatti P, Allegri RF. A double-blind, randomized clinical trial to assess the augmentation with nimodipine of antidepressant therapy in the treatment of “vascular depression”. Int Psychogeriatr. 2005;17(3):487–98.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag London
About this chapter
Cite this chapter
Thomas, A.J. (2013). Vascular Depression. In: Ferro, J. (eds) Neuropsychiatric Symptoms of Cerebrovascular Diseases. Neuropsychiatric Symptoms of Neurological Disease. Springer, London. https://doi.org/10.1007/978-1-4471-2428-3_13
Download citation
DOI: https://doi.org/10.1007/978-1-4471-2428-3_13
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-2427-6
Online ISBN: 978-1-4471-2428-3
eBook Packages: MedicineMedicine (R0)